The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Share News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,325.00
Bid: 11,150.00
Ask: 11,500.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.139%)
Open: 11,375.00
High: 11,300.00
Low: 11,300.00
Prev. Close: 11,400.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Judges Scientific lifts interim dividend, sees FY ahead of expectations

Fri, 24th Sep 2021 07:49

(Sharecast News) - Judges Scientific hiked its interim dividend by 15% on Friday as it reported a jump in profit and said it's confident of exceeding market expectations for the full year as it recovers from the initial impact of the pandemic.
In the six months to 30 June, adjusted pre-tax profit rose 31.5% to £8.5m on revenue of £43m, up 14.7% on the same period a year ago. The interim dividend per share was lifted to 19p from 16.5p.

Judges said the first half of 2021 marked a significant improvement following the difficulties caused by Covid-19 in 2020.

Organic order intake was up 25% compared to the same period last year. The company said order progress was strongest in geographies that were hit the hardest last year, with North America up 41%, the Rest of Europe up 34%, the UK 26% higher, China/Hong Kong up 2% and the Rest of the World 8% higher.

"As the group emerges from the worst of the pandemic, it is still faced by many challenges; whilst traveling restrictions and university closures are progressively alleviated, capital expenditure freezes are still affecting some of our operations and supply chain issues, which were benign in 2020, are now generating much unproductive management effort," it said.

"Nevertheless, the company is consolidating its recovery: organic order intake remains positive and for the eight months to the end of August was 23% up on 2020, when the total order book stood at 20.1 weeks.

"Our financial position is robust and the board has confidence that the performance for the year as a whole will be ahead of consensus expectations."

At 1015 BST, the shares were up 7.1% at 7,500p.
More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.